Ophthalmology News

In this episode, hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest news in eye care, then speak with Eric Rosenberg, DO, about the current state and future of digital ophthalmology.

Cathleen M. McCabe, MD, and Laura B. Enyedi, MD, talk with Jaya B. Kumar, MD, FASRS, and Jullia A. Rosdahl, MD, PhD, about addressing physician suicide and destigmatizing mental health. Plus, they share their favorite resilience hacks.

Although COVID-19 remained a popular topic among Healio Primary Care readers in 2021, other stories that discussed diabetes screening and physician suicide also generated significant attention.

As of Dec. 1, the FDA had approved 46 novel drugs this year, one fewer than it had approved by the same date in 2020.

The risk for hydroxychloroquine retinopathy increases with higher dosing per actual and ideal body weight, and with longer duration of use, according to data presented at ACR Convergence 2021.

In 2019, more than 67 million adults in the U.S. reported having a disability, a 1% increase since the prevalence was last examined in 2016, according to findings published in JAMA Network Open.

Holding a family’s fragile, premature newborn is a humbling moment — especially as a newly minted doctor.

Eye exam reminders at every visit are associated with higher uveitis knowledge among patients with juvenile idiopathic arthritis and their parents, according to data published in Pediatric Rheumatology.

The U.S. Preventive Services Task Force has issued draft recommendations that state there is not enough evidence to assess the balance of benefits and harms of screening some adults for primary open-angle glaucoma and impaired visual acuity.

Novel therapeutic approaches and a robust drug pipeline may provide hope for patients with Sjögren’s syndrome, according to a presenter at the 2021 Congress of Clinical Rheumatology-East.